• Something wrong with this record ?

Analysis of early neonatal case fatality rate among newborns with congenital hydrocephalus, a 2000-2014 multi-country registry-based study

JA. Gili, JS. López-Camelo, WN. Nembhard, M. Bakker, HEK. de Walle, EB. Stallings, V. Kancherla, ECEMC Peripheral Group, P. Contiero, S. Dastgiri, ML. Feldkamp, A. Nance, M. Gatt, L. Martínez, MA. Canessa, B. Groisman, P. Hurtado-Villa, K....

. 2022 ; 114 (12) : 631-644. [pub] 20220528

Language English Country United States

Document type Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Intramural

Persistent link   https://www.medvik.cz/link/bmc22025205

Grant support
CC999999 Intramural CDC HHS - United States

BACKGROUND: Congenital hydrocephalus (CH) comprises a heterogeneous group of birth anomalies with a wide-ranging prevalence across geographic regions and registry type. The aim of the present study was to analyze the early neonatal case fatality rate (CFR) and total birth prevalence of newborns diagnosed with CH. METHODS: Data were provided by 25 registries from four continents participating in the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) on births ascertained between 2000 and 2014. Two CH rates were calculated using a Poisson distribution: early neonatal CFR (death within 7 days) per 100 liveborn CH cases (CFR) and total birth prevalence rate (BPR) per 10,000 births (including live births and stillbirths) (BPR). Heterogeneity between registries was calculated using a meta-analysis approach with random effects. Temporal trends in CFR and BPR within registries were evaluated through Poisson regression modeling. RESULTS: A total of 13,112 CH cases among 19,293,280 total births were analyzed. The early neonatal CFR was 5.9 per 100 liveborn cases, 95% confidence interval (CI): 5.4-6.8. The CFR among syndromic cases was 2.7 times (95% CI: 2.2-3.3) higher than among non-syndromic cases (10.4% [95% CI: 9.3-11.7] and 4.4% [95% CI: 3.7-5.2], respectively). The total BPR was 6.8 per 10,000 births (95% CI: 6.7-6.9). Stratified by elective termination of pregnancy for fetal anomalies (ETOPFA), region and system, higher CFR were observed alongside higher BPR rates. The early neonatal CFR and total BPR did not show temporal variation, with the exception of a CFR decrease in one registry. CONCLUSIONS: Findings of early neonatal CFR and total BPR were highly heterogeneous among registries participating in ICBDSR. Most registries with higher CFR also had higher BPR. Differences were attributable to type of registry (hospital-based vs. population-based), ETOPFA (allowed yes or no) and geographical regions. These findings contribute to the understanding of regional differences of CH occurrence and early neonatal deaths.

Birth Defects Epidemiology and Surveillance Branch Texas Department of State Health Services Austin Texas USA

CARIS The Congenital Anomaly Register for Wales Singleton Hospital Swansea Wales UK

Department of Basic Sciences of Health School of Health Pontificia Universidad Javeriana Cali Colombia

Department of Epidemiology Arkansas Center for Birth Defects Research and Prevention and Arkansas Reproductive Health Monitoring System University of Arkansas for Medical Sciences Little Rock Arkansas USA

Department of Epidemiology Emory University Rollins School of Public Health Atlanta Georgia USA

Department of Genetics RYVEMCE Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán México City Mexico

Department of Genetics University of Groningen University Medical Center Groningen EUROCAT Northern Netherlands Groningen The Netherlands

Department of Medical Genetics Thomayer University Hospital Prague Czech Republic

Department of Neonatology Soroka Medical Center Beer Sheva Israel

Division of Medical Genetics Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah USA

ECLAMC Centro de Educación Médica e Investigaciones Clínicas Buenos Aires Argentina

Genetics Department Hospital Universitario Dr José E González Universidad Autonóma de Nuevo León San Nicolás de los Garza Mexico

Health Services Management Research Centre Tabriz University of Medical Sciences Tabriz Iran

Human Genetics Institute Pontificia Universidad Javeriana Bogotá Colombia

Institute of Clinical Physiology National Research Council and Fondazione Toscana Gabriele Monasterio Tuscany Registry of Congenital Defects Pisa Italy

Instituto Académico Pedagógico de Ciencias Humanas Universidad Nacional de Villa María Córdoba Argentina

International Center on Birth Defects International Clearinghouse for Birth Defects Surveillance and Research Rome Italy

Lombardy Congenital Anomalies Registry Cancer Registry Unit Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

Malta Congenital Anomalies Registry Directorate for Health Information and Research Tal Pietà Malta

Medical Faculty Malformation Monitoring Centre Saxony Anhalt Otto von Guericke University Magdeburg Germany

Metro Atlanta Congenital Defects Program Division of Birth Defects and Infant Disorders National Center on Birth Defects and Developmental Disabilities CDC Atlanta Georgia USA

National Board of Health and Welfare Stockholm Sweden

National Network of Congenital Anomalies of Argentina National Ministry of Health and Social Development Buenos Aires Argentina

Omni Net for Children International Charitable Fund Rivne Ukraine

Regional Register Congenital Malformation Maule Health Service Maule Chile

Slovak Teratologic Information Centre Slovak Medical University Bratislava Slovak Republic

Université de Paris CRESS Obstetrical Perinatal and Pediatric Epidemiology Research Team INSERM INRA Paris France

Utah Birth Defect Network Bureau of Children with Special Health Care Needs Division of Family Health and Preparedness Utah Department of Health Salt Lake City Utah USA

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025205
003      
CZ-PrNML
005      
20221031101226.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/bdr2.2045 $2 doi
035    __
$a (PubMed)35633200
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gili, Juan Antonio $u ECLAMC, Centro de Educación Médica e Investigaciones Clínicas (CEMIC-CONICET), Buenos Aires, Argentina $u Instituto Académico Pedagógico de Ciencias Humanas, Universidad Nacional de Villa María, Córdoba, Argentina $1 https://orcid.org/0000000179240776
245    10
$a Analysis of early neonatal case fatality rate among newborns with congenital hydrocephalus, a 2000-2014 multi-country registry-based study / $c JA. Gili, JS. López-Camelo, WN. Nembhard, M. Bakker, HEK. de Walle, EB. Stallings, V. Kancherla, ECEMC Peripheral Group, P. Contiero, S. Dastgiri, ML. Feldkamp, A. Nance, M. Gatt, L. Martínez, MA. Canessa, B. Groisman, P. Hurtado-Villa, K. Källén, D. Landau, N. Lelong, M. Morgan, J. Arteaga-Vázquez, A. Pierini, A. Rissmann, A. Sipek, E. Szabova, W. Wertelecki, I. Zarante, MA. Canfield, P. Mastroiacovo
520    9_
$a BACKGROUND: Congenital hydrocephalus (CH) comprises a heterogeneous group of birth anomalies with a wide-ranging prevalence across geographic regions and registry type. The aim of the present study was to analyze the early neonatal case fatality rate (CFR) and total birth prevalence of newborns diagnosed with CH. METHODS: Data were provided by 25 registries from four continents participating in the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR) on births ascertained between 2000 and 2014. Two CH rates were calculated using a Poisson distribution: early neonatal CFR (death within 7 days) per 100 liveborn CH cases (CFR) and total birth prevalence rate (BPR) per 10,000 births (including live births and stillbirths) (BPR). Heterogeneity between registries was calculated using a meta-analysis approach with random effects. Temporal trends in CFR and BPR within registries were evaluated through Poisson regression modeling. RESULTS: A total of 13,112 CH cases among 19,293,280 total births were analyzed. The early neonatal CFR was 5.9 per 100 liveborn cases, 95% confidence interval (CI): 5.4-6.8. The CFR among syndromic cases was 2.7 times (95% CI: 2.2-3.3) higher than among non-syndromic cases (10.4% [95% CI: 9.3-11.7] and 4.4% [95% CI: 3.7-5.2], respectively). The total BPR was 6.8 per 10,000 births (95% CI: 6.7-6.9). Stratified by elective termination of pregnancy for fetal anomalies (ETOPFA), region and system, higher CFR were observed alongside higher BPR rates. The early neonatal CFR and total BPR did not show temporal variation, with the exception of a CFR decrease in one registry. CONCLUSIONS: Findings of early neonatal CFR and total BPR were highly heterogeneous among registries participating in ICBDSR. Most registries with higher CFR also had higher BPR. Differences were attributable to type of registry (hospital-based vs. population-based), ETOPFA (allowed yes or no) and geographical regions. These findings contribute to the understanding of regional differences of CH occurrence and early neonatal deaths.
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a hydrocefalus $x epidemiologie $7 D006849
650    _2
$a novorozenec $7 D007231
650    _2
$a narození živého dítěte $x epidemiologie $7 D050498
650    _2
$a těhotenství $7 D011247
650    _2
$a prevalence $7 D015995
650    _2
$a registrace $7 D012042
650    12
$a narození mrtvého plodu $x epidemiologie $7 D050497
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
700    1_
$a López-Camelo, Jorge Santiago $u ECLAMC, Centro de Educación Médica e Investigaciones Clínicas (CEMIC-CONICET), Buenos Aires, Argentina
700    1_
$a Nembhard, Wendy N $u Department of Epidemiology, Arkansas Center for Birth Defects Research and Prevention and Arkansas Reproductive Health Monitoring System, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA $1 https://orcid.org/0000000283184049
700    1_
$a Bakker, Marian $u Department of Genetics, University of Groningen, University Medical Center Groningen, EUROCAT Northern Netherlands, Groningen, The Netherlands
700    1_
$a de Walle, Hermien E K $u Department of Genetics, University of Groningen, University Medical Center Groningen, EUROCAT Northern Netherlands, Groningen, The Netherlands
700    1_
$a Stallings, Erin B $u Metro Atlanta Congenital Defects Program (MACDP), Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia, USA $1 https://orcid.org/0000000204611410
700    1_
$a Kancherla, Vijaya $u Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia, USA $1 https://orcid.org/0000000228038030
700    1_
$a Contiero, Paolo $u Lombardy Congenital Anomalies Registry, Cancer Registry Unit, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy
700    1_
$a Dastgiri, Saeed $u Health Services Management Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran
700    1_
$a Feldkamp, Marcia L $u Division of Medical Genetics, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA $1 https://orcid.org/0000000191717848
700    1_
$a Nance, Amy $u Utah Birth Defect Network, Bureau of Children with Special Health Care Needs, Division of Family Health and Preparedness, Utah Department of Health, Salt Lake City, Utah, USA $1 https://orcid.org/000000024326890X
700    1_
$a Gatt, Miriam $u Malta Congenital Anomalies Registry, Directorate for Health Information and Research, Tal-Pietà, Malta
700    1_
$a Martínez, Laura $u Genetics Department, Hospital Universitario Dr. José E. González, Universidad Autonóma de Nuevo León, San Nicolás de los Garza, Mexico
700    1_
$a Canessa, María Aurora $u Regional Register Congenital Malformation Maule Health Service (RRMC-SSM), Maule, Chile
700    1_
$a Groisman, Boris $u National Network of Congenital Anomalies of Argentina (RENAC), National Center of Medical Genetics, National Administration of Laboratories and Health Institutes (ANLIS), National Ministry of Health and Social Development, Buenos Aires, Argentina $1 https://orcid.org/0000000162632562
700    1_
$a Hurtado-Villa, Paula $u Department of Basic Sciences of Health, School of Health, Pontificia Universidad Javeriana, Cali, Colombia $1 https://orcid.org/0000000338227780
700    1_
$a Källén, Karin $u National Board of Health and Welfare, Stockholm, Sweden
700    1_
$a Landau, Danielle $u Department of Neonatology, Soroka Medical Center, Beer-Sheva, Israel
700    1_
$a Lelong, Nathalie $u Université de Paris, CRESS Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRA, Paris, France
700    1_
$a Morgan, Margery $u CARIS, The Congenital Anomaly Register for Wales, Singleton Hospital, Swansea, Wales, UK
700    1_
$a Arteaga-Vázquez, Jazmín $u Department of Genetics, RYVEMCE, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico
700    1_
$a Pierini, Anna $u Institute of Clinical Physiology, National Research Council and Fondazione Toscana Gabriele Monasterio, Tuscany Registry of Congenital Defects, Pisa, Italy
700    1_
$a Rissmann, Anke $u Medical Faculty, Malformation Monitoring Centre Saxony-Anhalt, Otto-von-Guericke University, Magdeburg, Germany $1 https://orcid.org/0000000294372790
700    1_
$a Sipek, Antonin $u Department of Medical Genetics, Thomayer University Hospital, Prague, Czech Republic
700    1_
$a Szabova, Elena $u Slovak Teratologic Information Centre (FPH), Slovak Medical University, Bratislava, Slovak Republic
700    1_
$a Wertelecki, Wladimir $u Omni-Net for Children International Charitable Fund, Rivne, Ukraine $1 https://orcid.org/0000000158645985
700    1_
$a Zarante, Ignacio $u Human Genetics Institute, Pontificia Universidad Javeriana, Bogotá, Colombia $1 https://orcid.org/0000000207296866
700    1_
$a Canfield, Mark A $u Birth Defects Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas, USA
700    1_
$a Mastroiacovo, Pierpaolo $u International Center on Birth Defects, International Clearinghouse for Birth Defects Surveillance and Research, Rome, Italy
710    2_
$a ECEMC Peripheral Group
773    0_
$w MED00208301 $t Birth defects research $x 2472-1727 $g Roč. 114, č. 12 (2022), s. 631-644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35633200 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031101223 $b ABA008
999    __
$a ok $b bmc $g 1854751 $s 1176495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 114 $c 12 $d 631-644 $e 20220528 $i 2472-1727 $m Birth defects research $n Birth Defects Res $x MED00208301
GRA    __
$a CC999999 $p Intramural CDC HHS $2 United States
LZP    __
$a Pubmed-20221017

Find record

Citation metrics

Archiving options